GlassScriptPhysician profile
Abigail June Wrobleski
NPI 1538799572
$2,668.72
in general payments reported to CMS, 2019-2025
30 companies · $536 in 2025
The $536 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $438 · 2022: $891 · 2023: $398 · 2024: $406 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,339.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $847.24 | 2021-2025 | Wegovy |
| Medtronic, INC. | $330.02 | 2024-2025 | Ligasure, Signia |
| Abbvie INC. | $321.15 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $240.58 | 2022-2024 | Gattex |
| Lilly USA, LLC | $196.82 | 2021-2025 | Zepbound |
| Irhythm Technologies, INC. | $101.08 | 2022 | |
| Aimmune Therapeutics, INC. | $70.89 | 2024-2025 | Zenpep |
| Biohaven Pharmaceutical Holding Company LTD. | $47.66 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $47.65 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.52 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $42.58 | 2025 | |
| Ethicon US, LLC | $32.05 | 2024 | Echelon Flex, Enseal X1 |
| Organon LLC | $29.90 | 2021-2022 | |
| Tricoast Surgical Solutions LLC | $29.08 | 2024 | |
| Nestle Healthcare Nutrition INC. | $28.05 | 2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $24.34 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.09 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $20.86 | 2022 | |
| Impel Pharmaceuticals INC. | $19.79 | 2022 | |
| Vivus LLC | $19.04 | 2025 | Pancreaze |
| Phadia US INC. | $17.84 | 2022 | |
| Currax Pharmaceuticals LLC | $17.74 | 2024 | Contrave |
| Xeris Pharmaceuticals, INC. | $17.52 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.05 | 2022 | |
| Viiv Healthcare Company | $15.81 | 2022 | |
| Pfizer INC. | $15.48 | 2021 | |
| Glaxosmithkline, LLC. | $14.59 | 2022 | |
| Hologic Sales and Service, LLC | $13.87 | 2024 | Coolseal Generator |
| Boston Scientific Corporation | $13.86 | 2025 | Spyglass Discover |
| Bausch Health US, LLC | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Wrobleski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.